These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6242389)

  • 21. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
    Kinoshita T; Lavoie S; Nussenzweig V
    J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C3b inactivator and beta 1H.
    Crossley LG
    Methods Enzymol; 1981; 80 Pt C():112-24. PubMed ID: 6210825
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal glycoprotein activates the alternative complement pathway by reacting with factor H.
    Winsnes R; Lachmann PJ
    Scand J Immunol; 1982 Apr; 15(4):371-8. PubMed ID: 6213029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alternative complement pathway in chickens. Purification of factor B and production of a monospecific antibody against it.
    Koch C
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):253-9. PubMed ID: 3646826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    Lambris JD; Dobson NJ; Ross GD
    J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid.
    Carlo JR; Gammon WR; Sams WM; Ruddy S
    J Invest Dermatol; 1979 Dec; 73(6):551-3. PubMed ID: 390060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
    Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of the immune complex-complement interaction by protein H of the alternative complement pathway and the natural inhibitor heparin.
    Spycher MO; Nydegger UE
    Eur J Immunol; 1984 Mar; 14(3):276-9. PubMed ID: 6231187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
    Alsenz J; Lambris JD; Schulz TF; Dierich MP
    Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
    Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta 1H-hemagglutination assay: a highly sensitive test for human beta 1H and its uses.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol Methods; 1981; 47(1):75-85. PubMed ID: 6458635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').
    Nagasawa S; Stroud RM
    Immunochemistry; 1977; 14(11-12):749-56. PubMed ID: 146022
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolation of the fifth component of the bovine complement system.
    Aston WP; Mhatre A; Macrae J
    Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.
    Thompson RA; Winterborn MH
    Clin Exp Immunol; 1981 Oct; 46(1):110-9. PubMed ID: 6461451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.
    Koistinen V
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):317-9. PubMed ID: 1533511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.